ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research
December 5, 2024
ConcertAI and NeoGenomics announce a joint AI SaaS solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization. CTO-H provides a research